Markov Cohort Model
Cross-source consensus on Markov Cohort Model from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Evidence quality
Highlighted claims
- Costs and health outcomes were modelled using a Markov cohort model with monthly cycles and age-specific time-varying mortality. — Cost-effectiveness analysis of Canada’s National Overdose Response Service
- The evaluation used a retrospective cost-effectiveness analysis from the Canadian health-sector perspective. — Cost-effectiveness analysis of Canada’s National Overdose Response Service
- The model was calibrated to Canadian fatal overdose data from 2020 through 2023. — Cost-effectiveness analysis of Canada’s National Overdose Response Service
- The model population consisted of people actively using illicit drugs who could benefit from virtual overdose monitoring. — Cost-effectiveness analysis of Canada’s National Overdose Response Service
- The model excluded opioid agonist therapy and prescribed safer supply states because NORS was represented as a point-of-overdose intervention. — Cost-effectiveness analysis of Canada’s National Overdose Response Service